The move strengthens Sanofi’s presence in adult immunization by combining Dynavax’s innovative vaccines with Sanofi’s global scale and development capabilities
Study published in laboratory investigation, the official journal of the United States and Canadian Academy of Pathology
AFib is a progressive condition where timely intervention is critical to disease management and, ultimately, the patient's quality of life
This development marks a substantial improvement in the company's financial position and reflects strengthened promoter confidence
Xeureka will receive an upfront payment from UBE and will be eligible for milestone payments tied to future research progress
The MAR-Autism Test represents more than 20 years of research at the UC Davis MIND Institute by Judy Van de Water
Using a combination of blood and faecal samples, the service examines key biomarkers, including hereditary genetic status
The announcement came during the inauguration of the college’s Innovation & Incubation Centre and Health Club
Company acquires People Tree Hospital Yeshwanthpur for Rs. 430 crore
Subscribe To Our Newsletter & Stay Updated
